Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jul 10, 2020 10:53am
136 Views
Post# 31251323

RE:RE:RE:What will be the next good NEWS?

RE:RE:RE:What will be the next good NEWS?NewcamoStups, you have been talking about BLA and Riplazim years now.  imo, your guesses are a joke.  LMNL under new management has had to push out the BLA resubmission twice.

Your credibility is also stained by the fact you can't spell the product name correctly, for years.

What a doofus.


realstocky wrote: 1- BLA submission /riplazym 2- Riplazym partner$hip... imo leaks pushed this good last days tsx and lots more on nasdaq...stay tuned/good luck.


<< Previous
Bullboard Posts
Next >>